Show simple item record

FieldValueLanguage
dc.contributor.authorSpain, Malcolm
dc.contributor.authorWong, Joseph K.-H.
dc.contributor.authorNagalingam, Gayathri
dc.contributor.authorBatten, James M.
dc.contributor.authorHortle, Elinor
dc.contributor.authorOehlers, Stefan
dc.contributor.authorJiang, Xiao Fan
dc.contributor.authorMurage, Hasini E.
dc.contributor.authorOrford, Jack T.
dc.contributor.authorCrisologo, Patrick
dc.contributor.authorTriccas, James A.
dc.contributor.authorRutledge, Peter J.
dc.contributor.authorTodd, Matthew H.
dc.date.accessioned2020-05-07
dc.date.available2020-05-07
dc.date.issued2018-03-20
dc.identifier.citationSpain, M., Wong, J., Nagalingam, G., Batten, J., Hortle, E., Oehlers, S., Jiang, X., Murage, H., Orford, J., Crisologo, P., Triccas, J., Rutledge, P., Todd, M. (2018). Antitubercular bis-substituted cyclam derivatives: Structure-activity relationships and in vivo studies. Journal of Medicinal Chemistry, 61(8), 3595-3608.en
dc.identifier.urihttps://hdl.handle.net/2123/22236
dc.description.abstractWe recently reported the discovery of non-toxic cyclam-derived compounds that are active against drug-resistant Mycobacterium tuberculosis. In this paper we report exploration of the structure-activity relationship for this class of compounds, identifying several simpler compounds with comparable activity. The most promising compound identified, possessing significantly improved water solubility, displayed high levels of bacterial clearance in an in vivo zebrafish embryo model, suggesting this compound series has promise for in vivo treatment of tuberculosis.en
dc.description.sponsorshipThis work was supported by the National Health and Medical Research Council (NHMRC) Project APP1084266, the NHMRC Center of Research Excellence in Tuberculosis Control (APP1043225), Project Grant APP1099912, NHMRC CJ Martin Early Career Fellowship to S.O., APP1053407 and the University of Sydney Sydnovate Fund.en
dc.language.isoen_AUen
dc.publisherAmerican Chemical Societyen
dc.relationNHMRC Project (APP108426), NHMRC Center of Research Excellence in Tuberculosis Control (APP1043225), Project Grant APP1099912, NHMRC CJ Martin Early Career Fellowship to S.O. (APP1053407)en
dc.rightsOtheren
dc.subjectTuberculosis, mycobacteria, structure activity relationship, cyclam, in vivo studiesen
dc.titleAnti-Tubercular bis-Substituted Cyclam Derivatives: Structure-Activity Relationships and In Vivo Studiesen
dc.typeArticleen
dc.subject.asrc030207en
dc.subject.asrc030401en
dc.subject.asrc030503en
dc.identifier.doi10.1021/acs.jmedchem.7b01569
dc.type.pubtypePost-printen
usyd.facultyFaculty of Scienceen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.